7-chloro-4-[6-[2,2-difluoroethyl(sulfamoyl)amino]-2-azaspiro[3.3]heptan-2-yl]-5-methylpyrrolo[2,1-f][1,2,4]triazine
C15H19ClF2N6O2S — CID 163275514
Data last refreshed: (MolForge compound catalog, from PubChem)
About 7-chloro-4-[6-[2,2-difluoroethyl(sulfamoyl)amino]-2-azaspiro[3.3]heptan-2-yl]-5-methylpyrrolo[2,1-f][1,2,4]triazine
7-chloro-4-[6-[2,2-difluoroethyl(sulfamoyl)amino]-2-azaspiro[3.3]heptan-2-yl]-5-methylpyrrolo[2,1-f][1,2,4]triazine (PubChem CID 163275514) has the molecular formula C15H19ClF2N6O2S and a molecular weight of 420.87 g/mol. Its IUPAC name is 7-chloro-4-[6-[2,2-difluoroethyl(sulfamoyl)amino]-2-azaspiro[3.3]heptan-2-yl]-5-methylpyrrolo[2,1-f][1,2,4]triazine.
Molecular Properties
| Compound Name | 7-chloro-4-[6-[2,2-difluoroethyl(sulfamoyl)amino]-2-azaspiro[3.3]heptan-2-yl]-5-methylpyrrolo[2,1-f][1,2,4]triazine |
|---|---|
| PubChem CID | 163275514 |
| Molecular Formula | C15H19ClF2N6O2S |
| Molecular Weight | 420.87 g/mol |
| Exact Mass | 420.09 |
| IUPAC Name | 7-chloro-4-[6-[2,2-difluoroethyl(sulfamoyl)amino]-2-azaspiro[3.3]heptan-2-yl]-5-methylpyrrolo[2,1-f][1,2,4]triazine |
| SMILES | Cc1cc(Cl)n2ncnc(N3CC4(CC(N(CC(F)F)S(N)(=O)=O)C4)C3)c12 |
| InChI | InChI=1S/C15H19ClF2N6O2S/c1-9-2-11(16)24-13(9)14(20-8-21-24)22-6-15(7-22)3-10(4-15)23(5-12(17)18)27(19,25)26/h2,8,10,12H,3-7H2,1H3,(H2,19,25,26) |
| InChIKey | YNVFFXXBTFIVRQ-UHFFFAOYSA-N |
| XLogP | 1.43 |
| TPSA | 96.83 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 420.87 |
| LogP ≤ 5 | 1.43 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 163275514 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.